¼¼°èÀÇ Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå ¿¹Ãø : ±¸¼º¿ä¼Òº°, Áúȯº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(-2032³â)
AI In Mental Health Market Forecasts to 2032 - Global Analysis By Component (Solutions, Services), Disorder (Anxiety, Depression, Schizophrenia and Other Disorders), Technology, Application, End User and By Geography
»óǰÄÚµå : 1797927
¸®¼­Ä¡»ç : Stratistics Market Research Consulting
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200+ Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,150 £Ü 5,828,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,373,000
PDF (2-5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,350 £Ü 8,917,000
PDF & Excel (Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 5ȸ±îÁö °¡´ÉÇÕ´Ï´Ù. Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,533,000
PDF & Excel (Global Site License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 10ȸ±îÁö °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Stratistics MRC¿¡ µû¸£¸é ¼¼°è Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀåÀº 2025³â¿¡ 17¾ï ´Þ·¯, ¿¹Ãø ±â°£ µ¿¾È CAGRÀº 26.1%¸¦ ³ªÅ¸³»°í, 2032³â¿¡´Â 91¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI)Àº ½É¸®»óÅÂÀÇ Áø´Ü, Ä¡·á ¹× °ü¸®¸¦ °³¼±Çϱâ À§ÇÑ AI ±â¼úÀÇ ÀÀ¿ëÀ» ¸»ÇÕ´Ï´Ù. ÀΰøÁö´É(AI) ½Ã½ºÅÛÀº À½¼º, ÅØ½ºÆ®, Çൿ ÆÐÅÏ, »ýü µ¥ÀÌÅ͸¦ Æò°¡ÇÏ¿© Á¤½ÅÀû ¹®Á¦ÀÇ Á¶±â ÁöÇ¥¸¦ È®ÀÎÇϰí, Ä¡·á¸¦ »ç¿ëÀÚ Á¤ÀÇÇϰí, ½Ç½Ã°£À¸·Î ȯÀÚÀÇ °æ°ú¸¦ ÃßÀûÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÀ¿ë »ç·Ê·Î´Â Á¤½ÅÀû Áö¿øÀ» À§ÇÑ °¡»ó ¾î½Ã½ºÅÏÆ®, ÀÎÁö Çൿ Ä¡·á¸¦ À§ÇÑ Ã¤ÆÃº¿, ÀÚ»ì ¿¹¹æÀ» À§ÇÑ ¿¹Ãø ºÐ¼® µîÀÌ ÀÖ½À´Ï´Ù. ƯÈ÷ ºÒ¿ìÇÑ Áö¿ª¿¡¼­ AI´Â µ¥ÀÌÅÍ Áß½ÉÀÇ È®Àå °¡´ÉÇÏ°í ¾×¼¼½º °¡´ÉÇÑ Á¤½Å °Ç°­ °ü¸®¸¦ °¡´ÉÇϰÔÇÕ´Ï´Ù. ÇÁ¶óÀ̹ö½Ã, Æí°ß, ÀÓ»óÀû °ËÁõÀ» µÑ·¯½Ñ À±¸®Àû ¿ì·Á´Â °Ç°­ °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ Ã¥ÀÓÀÖ´Â ÅëÇÕ¿¡ ¿©ÀüÈ÷ Áß¿äÇÕ´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO)ÀÇ º¸°í¿¡ µû¸£¸é 2019³â¿¡´Â ¼¼°è¿¡¼­ ¾à 9¾ï 7,000¸¸ ¸íÀÌ Á¤½ÅÀå¾Ö¸¦ °®°í »ýȰÇϰí ÀÖ½À´Ï´Ù.

Á¤½Å °Ç°­ ÁúȯÀÇ À¯º´·ü Áõ°¡

Á¤½Å°Ç°­ ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀåÀÇ ¼ºÀåÀ» Å©°Ô ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ºÒ¾È, ¿ì¿ïÁõ, PTSD¿Í °°Àº »óŰ¡ ¿¬·ÉÃþ°ú Áö¿ªÀ» ³Ñ¾î È®»êµÊ¿¡ µû¶ó Àû½Ã¿¡ Á¤È®Çϰí È®Àå °¡´ÉÇÑ Áø´Ü ¹× Ä¡·á µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´ÉÀ» °®Ãá Ç÷§ÆûÀº Á¶±â ¹ß°ß, ¿ø°Ý ¸ð´ÏÅ͸µ ¹× °³ÀÎÈ­µÈ Ä¡·á °èȹÀ» Á¦°øÇÏ¿© Á¤½Å °Ç°­ °ü¸®¸¦ ´õ¿í Ä£¼÷Çϰí È¿À²ÀûÀ¸·Î ¸¸µì´Ï´Ù. ÀÌ·¯ÇÑ À¯º´·ü Áõ°¡´Â Çõ½Å°ú äÅÃÀ» ÃËÁøÇÏ°í µðÁöÅÐ Á¤½Å °Ç°­ÀÇ Çõ½ÅÀûÀÎ ¹Ì·¡¸¦ Çü¼ºÇÕ´Ï´Ù.

½Ã½ºÅÛ µð¹ö±ë ¹× À¯Áö º¸¼öÀÇ º¹À⼺

½Ã½ºÅÛ µð¹ö±ë°ú À¯Áö º¸¼öÀÇ º¹À⼺Àº Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå¿¡ Å« ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÑ ½Ã½ºÅÛÀº ¹®Á¦ ÇØ°áÀ» À§ÇØ Àü¹® Áö½ÄÀ» ÇÊ¿ä·Î ÇÏ¸ç ¿î¿µ ºñ¿ëÀ» Áõ°¡½ÃŰ°í ¹èÆ÷¸¦ Áö¿¬½Ãŵ´Ï´Ù. ½Ã½ºÅÛ ¿À·ù³ª Àå¾Ö°¡ ÀÚÁÖ ¹ß»ýÇϸé ȯÀÚÀÇ Äɾ ÁöÀåÀ» ÃÊ·¡ÇÏ¿© ÀÓ»óÀÇ¿Í »ç¿ëÀÚÀÇ ½Å·Ú°¡ ¼Õ»óµÉ ¼ö ÀÖ½À´Ï´Ù. ±× °á°ú, ÀÌ ½ÃÀå¿¡¼­´Â äÅ÷üÀÌ ÀúÇϵǾî, ÀÇ·á Á¦°øÀڷκÎÅÍÀÇ µµÀÔÀÌ ÁÖÀúµÇ°í, °á±¹ AI ÁÖµµÇü ¼Ö·ç¼ÇÀÇ ¼ºÀå°ú È®À强ÀÇ ¹æÇذ¡ µÇ°í ÀÖ½À´Ï´Ù.

NLP¿Í ¸Ó½Å·¯´×ÀÇ Áøº¸

ÀÚ¿¬¾ð¾îó¸®(NLP)¿Í ¸Ó½Å·¯´×(ML)ÀÇ Áøº¸´Â Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå ¼ºÀå¿¡ ÀÖ¾î °­·ÂÇÑ Ã˸ÅÁ¦·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀ» ÅëÇØ AI ½Ã½ºÅÛÀº Àΰ£ÀÇ °¨Á¤, ¹ßÈ­ ÆÐÅÏ, Çൿ ½ÅÈ£¸¦ ´õ ±íÀÌ ÀÌÇØÇϰí ÇØ¼®ÇÏ¸ç ´µ¾Ó½º¿Í Á¤È®¼ºÀ» ³ôÀÌ°í ´ëÀÀÇÒ ¼ö ÀÖ½À´Ï´Ù. À̰ÍÀº Á¤½Å °Ç°­ »óÅÂÀÇ Á¶±â ¹ß°ß, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ¹× °³ÀÎÈ­ Ä¡·á¸¦ °­È­ÇÕ´Ï´Ù. ±× °á°ú, AI ÅøÀº º¸´Ù °ø°¨ÀûÀ̰í, ÀÀ´ä¼ºÀÌ ³ô°í, ½Å·ÚÇÒ ¼ö ÀÖ°Ô µÇ¾î, ¸àÅ» ÇコÄÉ¾î ½Ã½ºÅÛ Àüü¿¡ ³Î¸® äÅÃµÇ°Ô µÇ¾ú½À´Ï´Ù.

AI ¾Ë°í¸®ÁòÀÇ Á¦ÇÑµÈ ÀÓ»ó °ËÁõ

AI ¾Ë°í¸®ÁòÀÇ Á¦ÇÑµÈ ÀÓ»ó °ËÁõÀº Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI)ÀÇ ½Å·Ú¼º, äÅà ¹× È®À强À» ÇöÀúÇÏ°Ô ÀúÇØÇÕ´Ï´Ù. ¾ö°ÝÇÑ °ËÁõÀÌ ¾øÀ¸¸é ÀÇ·á Àü¹®°¡´Â AI µµ±¸¿¡ ȸÀÇÀûÀÎ »óŸ¦ À¯ÁöÇÏ¸ç ºÎÁ¤È®¼º°ú ¿ÀÁøÀ» µÎ·Á¿öÇÕ´Ï´Ù. ÀÌ·Î ÀÎÇØ ÀÓ»ó ¿öÅ©Ç÷οì·ÎÀÇ ÅëÇÕÀÌ ÀúÇØµÇ°í ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀÌ Áö¿¬µË´Ï´Ù. ½Ç»çȸ¿¡¼­ÀÇ Áõ°Å°¡ ¾ø±â ¶§¹®¿¡ ÅõÀÚ¿Í ÆÄÆ®³Ê½ÊÀÌ ´õ¿í ÀúÇØµÇ¾î ±Ã±ØÀûÀ¸·Î ±â¼ú Çõ½ÅÀÌ Áö¿¬µÇ°í Àû½Ã¿¡ Á¤½Å°Ç°­ °³ÀÔÀ¸·ÎºÎÅÍ °¡Àå ÇýÅÃÀ» ¹ÞÀ» ¼ö Àִ ȯÀÚ¿¡°Ô ÀÌ·¯ÇÑ ±â¼úÀÌ °¡±î¿öÁö´Â °ÍÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ ´ëÀ¯ÇàÀº Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀåÀÇ ¼ºÀåÀ» ÇöÀúÇÏ°Ô °¡¼ÓÈ­Çß½À´Ï´Ù. °í¸³, ºÒ¾È, °æÁ¦Àû ½ºÆ®·¹½º·Î ÀÎÇÑ Á¤½Å °Ç°­ ¹®Á¦°¡ Áõ°¡ÇÔ¿¡ µû¶ó Á¢±Ù °¡´ÉÇϰí È®Àå °¡´ÉÇÑ Á¤½Å °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù. ÀΰøÁö´ÉÀÌ Å¾ÀçµÈ Ç÷§ÆûÀº ¿ø°Ý »ó´ã, ±âºÐ º¯È­ ¸ð´ÏÅ͸µ, Á¶±â Áø´Ü µµ±¸¸¦ Á¦°øÇÏ¿© Àá±×´Â µ¿¾È °ü¸® °ÝÂ÷¸¦ ¸Þ¿ì´Â µ¥ µµ¿òÀÌ µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ À§±â »óȲ ÇÏ¿¡¼­ÀÇ Ã¤ÅÃÀº ¼¼°è Á¤½Å °Ç°­ °ü¸® Á¦°øÀÇ º¯È­¿¡ À־ AIÀÇ Áß¿äÇÑ ¿ªÇÒÀ» ºÎ°¢½ÃÄ×½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¸Ó½Å·¯´×(ML) ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ °ÍÀ¸·Î ¿¹»ó

¸Ó½Å·¯´×(ML) ºÎ¹®Àº MLÀÌ ´õ ³ôÀº Á¤È®µµ·Î ¿ì¿ïÁõ, ºÒ¾È, PTSD¿Í °°Àº Á¤½Å °Ç°­ »óÅÂÀÇ Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô Çϱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ Áö´ÉÇü ½Ã½ºÅÛÀº Ä¡·á ±ÇÀå »çÇ×À» °³ÀÎÈ­ÇÏ°í ½Ç½Ã°£À¸·Î Çൿ ÆÐÅÏÀ» ¸ð´ÏÅ͸µÇϸç Áø´Ü ¹× Ä¡·á °èȹ¿¡¼­ ÀÓ»óÀǸ¦ Áö¿øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â¼ú Çõ½ÅÀº Äɾ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó °³ÀÎÀûÀÎ ±â¼ú ´ëÀÀ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ½ºÆ¼±×¸¶¸¦ ÁÙÀÌ°í ½ÃÀå ¼ºÀåÀ» ²ÙÁØÈ÷ ÀüÁø½Ãŵ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ÀÓ»ó ¿¬±¸ ºÎ¹®ÀÇ CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»ó

¿¹Ãø ±â°£ µ¿¾È ¾Ë°í¸®ÁòÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀ» ³ôÀÌ´Â °ß°íÇÑ µ¥ÀÌÅÍ ¼¼Æ®¿Í ½Ç¼¼°è ÅëÂû·ÂÀ¸·Î ÀÓ»ó ¿¬±¸ ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÓ»ó ¹× Á¾´Ü ¿¬±¸´Â Á¶±â ¹ß°ß, °³ÀÎÈ­ Ä¡·á ¹× À§Çè Æò°¡¸¦ À§ÇÑ AI ±¸µ¿ ¿¹Ãø ¸ðµ¨ÀÇ °³¹ß¿¡ ±â¿©ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Áõ°Å ±â¹ÝÀÇ ±â¹ÝÀº °Ç°­ °ü¸® Á¦°ø¾÷üÀÇ ½Å·Ú¸¦ ±¸ÃàÇϰí, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ» °¡¼ÓÈ­Çϰí, º¸´Ù ±¤¹üÀ§ÇÑ Ã¤ÅÃÀ» ÃËÁøÇÕ´Ï´Ù. ÀÓ»ó °ËÁõÀÌ °­È­µÊ¿¡ µû¶ó Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ¼Ö·ç¼ÇÀº ´õ¿í È¿°úÀûÀ̰í À±¸®ÀûÀÌ µÇ¾î °Ç°­ °ü¸® ½Ã½ºÅÛ Àü¹Ý¿¡ °ÉÃÄ ³Î¸® ¹Þ¾Æµé¿©Áý´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÎÁöµµ Çâ»ó, Á¤½Å °Ç°­ Àå¾Ö Áõ°¡, ½º¸¶Æ®Æù º¸±Þ·ü Áõ°¡·Î ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀΰøÁö´ÉÀÌ Å¾ÀçµÈ µµ±¸´Â Á¶±â Áø´Ü, ½Ç½Ã°£ ¸ð´ÏÅ͸µ, °³ÀÎÈ­ Ä¡·á¸¦ °¡´ÉÇÏ°Ô Çϸç, ¿ø°ÝÁö³ª ¼­ºñ½º°¡ °¡µæ Â÷Áö ¾ÊÀº Áö¿ªÀÇ Ä¡·á °¸À» ¸Þ¿ì°í ÀÖ½À´Ï´Ù. Á¤ºÎ ¹× ÀÇ·á Á¦°øÀÚ´Â µðÁöÅÐ Á¤½Å°Ç°­ Ç÷§Æû¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç Å×Å©°è ½ÅÈï±â¾÷Àº ºü¸£°Ô Çõ½ÅÇϰí ÀÖ½À´Ï´Ù. ÀÌ ±â¼¼´Â Áø·á Á¦°ø¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ Á¤½Å °Ç°­À» µÑ·¯½Ñ »çȸÀû Æí°ßÀ» ÁÙÀÔ´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµÇÁö¸¸, ÀÌ´Â ±â¼úÀÇ Áøº¸, °­·ÂÇÑ °Ç°­ °ü¸® ÀÎÇÁ¶ó ¹× Á¤½Å °Ç°­ ÀÎ½Ä Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â AI¸¦ žÀçÇÑ Áø´Ü Åø, 꺿, °¡»ó Å×¶óÇǽºÆ®ÀÇ Á¶±â µµÀÔÀ¸·Î Àû½Ã °³ÀÔ°ú ¸ÂÃãÇü Ä¡·á°¡ °¡´ÉÇØ ȯÀÚ Äɾ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ Áö¿ø°ú µðÁöÅÐ °Ç°­ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡´Â Áøº¸¸¦ ´õ¿í ÁõÆø½Ãŵ´Ï´Ù. ÀÌ¿ëÇϱ⠽¬¿î Á¤½Å°Ç°­ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö´Â °¡¿îµ¥, AI´Â ƯÈ÷ ÃæºÐÇÑ ¼­ºñ½º¸¦ ¹ÞÁö ¸øÇÑ ¿ø°ÝÁö Ä¿¹Â´ÏƼ¿¡¼­ Äɾî Á¦°øÀÇ °¸À» ¸Þ¿ì°í ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

Á¦4Àå Porter's Five Forces ºÐ¼®

Á¦5Àå ¼¼°è Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : ±¸¼º¿ä¼Òº°

Á¦6Àå ¼¼°è Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : Áúº´º°

Á¦7Àå ¼¼°è Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : ±â¼úº°

Á¦8Àå ¼¼°è Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : ¿ëµµº°

Á¦9Àå ¼¼°è Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ¼¼°è Á¤½Å°Ç°­ ºÐ¾ß ÀΰøÁö´É(AI) ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä ¹ßÀü

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

According to Stratistics MRC, the Global AI In Mental Health Market is accounted for $1.7 billion in 2025 and is expected to reach $9.1 billion by 2032 growing at a CAGR of 26.1% during the forecast period. Artificial intelligence (AI) in mental health refers to the application of AI technology to improve psychological condition diagnosis, treatment, and management. Artificial intelligence (AI) systems can identify early indicators of mental problems, customize therapy, and track patient progress in real time by evaluating voice, text, behavior patterns, and biometric data. Applications include virtual assistants for emotional support, chatbots for cognitive behavioral therapy, and predictive analytics for preventing suicide. Particularly in underprivileged areas, AI makes data-driven, scalable, and accessible mental health care possible. While promising, ethical concerns around privacy, bias, and clinical validation remain critical to its responsible integration into healthcare systems.

According to World Health Organization (WHO) report, approximately 970 million people worldwide were living with a mental disorder in 2019.

Market Dynamics:

Driver:

Rising Prevalence of Mental Health Disorders

The rising prevalence of mental health disorders is significantly driving growth in the AI in Mental Health Market. As conditions like anxiety, depression, and PTSD become more widespread across age groups and geographies, there is growing demand for timely, accurate, and scalable diagnostic and therapeutic tools. AI-powered platforms offer early detection, remote monitoring, and personalized treatment plans, making mental health care more accessible and efficient. This rising burden fuels innovation and adoption, shaping a transformative future for digital mental health.

Restraint:

Complexity of system debugging & maintenance

The complexity of system debugging and maintenance poses a significant challenge to the AI in Mental Health market. These intricate systems require specialized expertise for troubleshooting, which escalates operational costs and delays deployment. Frequent system errors or failures can disrupt patient care and erode trust among clinicians and users. As a result, the market experiences slower adoption rates and hesitancy from healthcare providers, ultimately hindering the growth and scalability of AI-driven solutions.

Opportunity:

Advancements in NLP and Machine Learning

Advancements in Natural Language Processing (NLP) and Machine Learning (ML) are acting as a powerful catalyst in the growth of the AI in Mental Health Market. These technologies enable AI systems to better understand, interpret, and respond to human emotions, speech patterns, and behavioral cues with greater nuance and accuracy. This enhances early detection, continuous monitoring, and personalized treatment of mental health conditions. As a result, AI tools are becoming more empathetic, responsive, and reliable, driving widespread adoption across mental health care systems.

Threat:

Limited Clinical Validation of AI Algorithms

Limited clinical validation of AI algorithms significantly hampers trust, adoption, and scalability in the AI in Mental Health Market. Without rigorous validation, healthcare professionals remain skeptical of AI tools, fearing inaccuracies and misdiagnosis. This undermines integration into clinical workflows and stalls regulatory approvals. The lack of real-world evidence further deters investments and partnerships, ultimately slowing innovation and preventing these technologies from reaching patients who could benefit most from timely mental health interventions.

Covid-19 Impact

The Covid-19 pandemic significantly accelerated the growth of the AI in Mental Health Market. With increased mental health issues arising from isolation, anxiety, and economic stress, there was a surge in demand for accessible, scalable mental health solutions. AI-powered platforms offered remote counseling, mood tracking, and early diagnosis tools, helping bridge care gaps during lockdowns. This crisis-driven adoption highlighted AI's critical role in transforming mental healthcare delivery globally.

The machine learning (ML) segment is expected to be the largest during the forecast period

The machine learning (ML) segment is expected to account for the largest market share during the forecast period because ML enables early detection of mental health conditions such as depression, anxiety, and PTSD with higher accuracy. These intelligent systems can personalize therapy recommendations, monitor behavioral patterns in real time, and support clinicians in diagnosis and treatment planning. This innovation not only enhances accessibility to care but also reduces stigma by offering private, tech-enabled solutions, propelling market growth steadily forward.

The clinical research segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the clinical research segment is predicted to witness the highest growth rate, due to robust data sets and real-world insights that enhance algorithm accuracy and reliability. Clinical trials and longitudinal studies fuel the development of AI-driven predictive models for early detection, personalized treatment, and risk assessment. This evidence-based foundation builds trust among healthcare providers and accelerates regulatory approvals, driving broader adoption. As clinical validation strengthens, AI solutions in mental health become more effective, ethical, and widely accepted across healthcare systems.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising awareness, increasing mental health disorders, and growing smartphone penetration. AI-powered tools are enabling early diagnosis, real-time monitoring, and personalized therapy, bridging the treatment gap in remote and underserved areas. Governments and healthcare providers are investing in digital mental health platforms, while tech start-ups are innovating rapidly. This momentum is revolutionizing care delivery and reducing the social stigma surrounding mental health.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to technological advancements, strong healthcare infrastructure, and rising mental health awareness. The region's early adoption of AI-powered diagnostic tools, chatbots, and virtual therapists is transforming patient care by enabling timely intervention and personalized treatment. Government support and increased investments in digital health solutions further amplify progress. With a growing demand for accessible mental health services, AI is bridging gaps in care delivery, especially in underserved and remote communities.

Key players in the market

Some of the key players profiled in the AI In Mental Health Market include Woebot Health, Quartet Health, Talkspace, Wysa, Spring Health, Ada Health, Lyra Health, 7 Cups, Mindstrong Health, Limbix, Youper, Happify Health, Cognoa, Big Health, Eleos Health, Meru Health, Modern Health, Kintsugi and Cerebral.

Key Developments:

In August 2025, Cerebral, a virtual mental health provider, acquired Resilience Lab to scale its outcomes-focused care model and clinician development platform. The move integrates psychiatry and therapy into a single digital pathway, aiming to improve care consistency and workforce sustainability.

In January 2025, Eleos Health secured $60M in Series C funding to expand its AI-powered behavioral health platform. Coinciding with the funding, it launched Eleos Compliance, a clinical documentation improvement tool that uses agentic AI to flag errors and streamline accreditation.

In June 2024, Ada Health expanded its leadership team and announced new partnerships with healthcare systems and life sciences companies. It also launched Care Journeys, an AI-powered solution guiding high-risk patients to telehealth consultations, available across all 50 U.S. states.

Components Covered:

Disorders Covered:

Technologies Covered:

Applications Covered:

End Users Covered:

Regions Covered:

What our report offers:

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Table of Contents

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global AI In Mental Health Market, By Component

6 Global AI In Mental Health Market, By Disorder

7 Global AI In Mental Health Market, By Technology

8 Global AI In Mental Health Market, By Application

9 Global AI In Mental Health Market, By End User

10 Global AI In Mental Health Market, By Geography

11 Key Developments

12 Company Profiling

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â